Company / EPS (Diluted)
Wave Life Sciences Ltd. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.54
FY2025
5-year range
-$3.82 / -$0.54
FY2021-FY2025
Trend
+73.7%
vs FY2024
Sector context
#76 of 204
Health Care
What the data says
At $-0.54, Wave Life Sciences Ltd.'s eps (diluted) ranks #76 of 204 in the Health Care sector. Improved from $-2.05 to $-0.54 over the past 2 years.
Based on SEC 10-K filings.
-0.54 in FY2025.
Improved from $-2.05 to $-0.54 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 204 in Health CareTop 37% of 204This company -$0.54 Sector average -$0.89
▼
+39.1% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 73.7% year-over-year.
- Ranks #76 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.54 | +73.7% |
| FY2024 | -$2.05 | +0.0% |
| FY2023 | -$2.05 | +13.1% |
| FY2022 | -$2.36 | +38.2% |
| FY2021 | -$3.82 | +33.2% |
| FY2020 | -$5.72 | -48.6% |
| FY2019 | -$3.85 | -57.8% |
| FY2018 | -$2.44 | -33.3% |
| FY2017 | -$1.83 | -36.6% |
| FY2016 | -$1.34 | +29.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026